Capitalism is groovy, but at what cost?
Due to the COVID-19 pandemic, the FDA was forced to bypass normal protocol and issue Emergency Use Authorization for diagnostic testing. As a result, we have seen an explosion in the number of available molecular diagnostic tests developed by various private enterprises. Our case reports of an 85-ye...
Saved in:
Main Authors: | Krishna Vedala (Author), Phillip T Sobash (Author), Shiyu Wang (Author), Gilbert-Roy Kamoga (Author) |
---|---|
Format: | Book |
Published: |
Greater Baltimore Medical Center,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?
by: Krishna Vedala, et al.
Published: (2021) -
Identifying asymptomatic healthcare workers with COVID-19 in a community hospital: an institution's experience
by: Neal Mehta, et al.
Published: (2020) -
Electrolyte Replacement in Bartter Syndrome With Abnormal Small Bowel: A Case Report
by: Philip T. Sobash MD, et al.
Published: (2020) -
CK-MB Elevation in Mild Hypothermia: What We Did and We Should Have Done
by: Khalid Sawalha MD, et al.
Published: (2021) -
The Opportunity Cost of Capital
by: Ayman Chit PhD, et al.
Published: (2015)